Sitagliptin in the Elderly

PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions
Type 2 Diabetes
Interventions
DRUG

Sitagliptin 100 mg

All subjects will receive a single 100 mg dose of sitagliptin and a placebo. Which they are given first is determined randomly.

Trial Locations (1)

Unknown

University of British Columbia Gerontology & Diabetes Research Centre, Vancouver

All Listed Sponsors
collaborator

Merck Frosst Canada Ltd.

INDUSTRY

lead

University of British Columbia

OTHER

NCT00451113 - Sitagliptin in the Elderly | Biotech Hunter | Biotech Hunter